Insulin and the heart

Diabetes Research and Clinical Practice

Volumn 93, Issue SUPPL. 1, 2011, Pages

  Iliadis, Fotios ^a   Kadoglou, Nikolaos ^a   Didangelos, Triantafillos ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Coronary syndromes; Heart; Insulin; Type 2 diabetes

Indexed keywords

ANGIOTENSIN II; INSULIN; REACTIVE OXYGEN METABOLITE;

ACUTE CORONARY SYNDROME; APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; DIABETES MELLITUS; DRUG EFFICACY; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; HYPERGLYCEMIA; OXIDATIVE STRESS; PROTEIN SYNTHESIS; REPERFUSION INJURY;

ACUTE CORONARY SYNDROME; ANIMALS; DIABETES MELLITUS, TYPE 2; HEART; HUMANS; INSULIN; MODELS, BIOLOGICAL; MYOCARDIUM; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84860420845     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70019-5     Document Type: Article

References (48)

1. Bertrand L, Horman S, Beauloye C, Vanoverschelde JL Insulin signalling in the heart. Cardiovasc Res 2008, 79:238-248.
2. Opie LH, Sack MN Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemie preconditioning. J Mol Cell Cardiol 2002, 34:1077-1089.
3. Brownsey RW, Boone AN, Allard MF Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms. Cardiovasc Res 1997, 34:3-24.
4. Bézaire V, Seifert EL, Harper ME Uncoupling protein-3: clues in an ongoing mitochondrial mystery. FASEB J 2007, 21:312-324.
5. Stanley WC, Chandler MR Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev 2002, 7:115-130.
6. Opie LH. Mechanisms of cardiac contraction and relaxation. In: Braunwald E, ed. Heart Disease, 8th ed., 2007.
7. Maier S, Aulbach F, Simm A, Lange V, Langenfeld H, Behre H, et al. Stimulation of L-type Ca2+ current in human atrial myocytes by insulin. Cardiovasc Res 1999, 44:390-397.
8. von Lewinski D, Bruns S, Walther S, Kögler H, Pieske B Insulin causes [Ca2+]i -dependent and [Ca2+]i-ndependent positive inotropic effects in failing human myocardium. Circulation 2005, 111:2588-2595.
9. Teshima Y, Takahashi N, Saikawa T, Hara M, Yasunaga S, Hidaka S, et al. Diminished expression of sarcoplasmic reticulum Ca2+-ATPase and ryanodine sensitive Ca(2+ channel mRNA in streptozotocin-induced diabetic rat heart. J Mol Cell Cardiol 2000, 32:655-664.
10. Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, et al. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol 2008, 214:316-321.
11. Walsh K Akt signaling and growth of the heart. Circulation 2006, 113:2032-2034.
12. O'Neill BT, Abel ED Akt1 in the cardiovascular system: friend or foe?. J Clin Invest 2005, 115:2059-2064.
13. Duronio V The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 2008, 415:333-344.
14. Sundell J, Knuuti J Insulin and myocardial blood flow. Cardiovasc Res 2003, 57:312-319.
15. Yasui S, Mawatari K, Kawano T, Morizumi R, Hamamoto A, Furukawa H, et al. Insulin activates ATP-sensitive potassium channels via phosphatidylinositol 3-kinase in cultured vascular smooth muscle cells. J Vase Res 2008, 45:233-243.
16. Liu Z Insulin at physiological concentrations increases microvascular perfusion in human myocardium. Am J Physiol Endocrinol Metab 2007, 293:E1250-E1255.
17. Broder HJ, Nesto RW Glucose, insulin, and potassium for metabolic support in acute myocardial infarction: is the jury still out?. Rev Cardiovasc Med 2006, 7(Suppl):S44-S50.
18. Doenst T, Bugger H, Schwarzer M, Faerber G, Borger MA, Mohr FW Three good reasons for heart surgeons to understand cardiac metabolism. Eur J Cardiothorac Surg 2008, 33:862-871.
19. Dennis SC, Gevers W, Opie LH Protons in ischemia: where do they come from; where do they go to?. J Mol Cell Cardiol 1991, 23:1077-1086.
20. Beauloye C, Bertrand L, Krause U, Marsin AS, Dresselaers T, Vanstapel F, et al. No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH. Circ Res 2001, 88:513-519.
21. Dyck JR, Lopaschuk GD AMPK alterations in cardiac physiology and pathology: enemy or ally?. J Physiol 2006, 574:95-112.
22. Ferdinandy P, Schulz R, Baxter GF Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007, 59:418-458.
23. Liu B, el Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemie hearts. Am J Physiol 1996, 270:H72-H80.
24. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 2002, 39:718-725.
25. Tian R, Baischi JA Interaction of insulin and AMPK in the ischemic heart: another chapter in the book of metabolic therapy?. Circ Res 2006, 99:3-5.
26. Dandona P, Chaudhuri A, Ghanim H, Mohanty P Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol 2009, 53(Suppl):S14-S20.
27. Lautamäki R, Airaksinen KE, Seppänen M, Toikka J, Härkönen R, Luotolahti M, et al. Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. Diabetes 2006, 55:511-516.
28. Gandhi M, Finegan BA, Clanachan AS Role of glucose metabolism in the recovery of postischemic LV mechanical function: effects of insulin and other metabolic modulators. Am J Physiol Heart Circ Physiol 2008, 294:H2576-H2586.
29. Fath-Ordoubadi F, Beatt KJ Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997, 96:1152-1156.
30. van der Horst IC, Zijlstra F, van't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H, et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 2003, 42:784-791.
31. Mehta SR, Yusuf S, Dïaz R, Zhu J, Pais P, Xavier D, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005, 293:437-446.
32. Opie LH Glucose-insulin-potassium therapy in patients with STEMI - Reply. JAMA 2008, 299:2385.
33. Chaudhuri A, Nesto R, Dandona P Glucose-insulin-potassium therapy in patients with STEMI - Reply. JAMA 2008, 299:2386.
34. Su H, Sun X, Ma H, Zhang HF, Yu QJ, Huang C, et al. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab 2007, 293:E629-E635.
35. Heller SR Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome?. Int J Clin Pract Suppl 2002, 129:27-32.
36. Gill GV, Woodward A, Casson IF, Weston PJ Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes - the " dead in bed" syndrome revisited. Diabetologia 2009, 52:42-45.
37. Finck BN, Kelly DP Peroxisome prolifera tor-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 2007, 115:2540-2548.
38. Stanley WC, Recchia FA, Lopaschuk GD Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005, 85:1093-1129.
39. Boudina S, Abel ED Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) 2006, 21:250-258.
40. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007, 56:2457-2466.
41. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 2006, 55:466-473.
42. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004, 18:1692-1700.
43. Schenk S, Saberi M, Olefsky JM Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008, 118:2992-3002.
44. Lebeche D, Davidoff AJ, Hajjar RJ Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nat Clin Pract Cardiovasc Med 2008, 5:715-724.
45. Boudina S, Abel ED Diabetic cardiomyopathy revisited. Circulation 2007, 115:3213-3223.
46. Shao CH, Rozanski GJ, Patel KP, Bidasee KR Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats. J Mol Cell Cardiol 2007, 42:234-246.
47. Singh VP, Le B, Khode R, Baker KM, Kumar R Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 2008, 57:3297-3306.
48. Paul M, Poyan Mehr A, Kreutz R Physiology of local renin-angiotensin systems. Physiol Rev 2006, 86:747-803.